Cargando…
Catchet-MS identifies IKZF1-targeting thalidomide analogues as novel HIV-1 latency reversal agents
A major pharmacological strategy toward HIV cure aims to reverse latency in infected cells as a first step leading to their elimination. While the unbiased identification of molecular targets physically associated with the latent HIV-1 provirus would be highly valuable to unravel the molecular deter...
Autores principales: | Ne, Enrico, Crespo, Raquel, Izquierdo-Lara, Ray, Rao, Shringar, Koçer, Selin, Górska, Alicja, van Staveren, Thomas, Kan, Tsung Wai, van de Vijver, David, Dekkers, Dick, Rokx, Casper, Moulos, Panagiotis, Hatzis, Pantelis, Palstra, Robert-Jan, Demmers, Jeroen, Mahmoudi, Tokameh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177988/ https://www.ncbi.nlm.nih.gov/pubmed/35640596 http://dx.doi.org/10.1093/nar/gkac407 |
Ejemplares similares
-
A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency
por: Röling, Michael, et al.
Publicado: (2021) -
HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency
por: Crespo, Raquel, et al.
Publicado: (2022) -
The BAF complex and HIV latency
por: Mahmoudi, Tokameh
Publicado: (2012) -
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
por: Stoszko, Mateusz, et al.
Publicado: (2015) -
DEAD-ly Affairs: The Roles of DEAD-Box Proteins on HIV-1 Viral RNA Metabolism
por: Rao, Shringar, et al.
Publicado: (2022)